---
title: 'Associate Director, Global Scientific Communications at Bicara Therapeutics'
canonical: 'https://feeny.ai/job/associate-director-global-scientific-communications-bicara-therapeutics-boston-b20sj17zmqbw'
type: 'job'
last_seen: '2026-09-06'
---

# Associate Director, Global Scientific Communications at Bicara Therapeutics

- **Company:** Bicara Therapeutics
- **Location:** Boston, MA
- **Employment:** full-time
- **Work type:** hybrid
- **Posted:** 2026-07-06
- **Last confirmed live:** 2026-09-06
- **Apply:** https://jobs.ashbyhq.com/bicara-therapeutics/33db2847-e89f-4976-95f2-5037f8805948

## Job description

## POSITION OVERVIEW

Bicara Therapeutics is seeking an Associate Director, Global Scientific Communications, who will lead the development and execution of global scientific communication plans across key assets. This role is responsible for leading the end-to-end tactical execution of the scientific publication plan (60%), while operationalizing and pulling through the Scientific Communication Platform (SCP) into all deliverables (20%) and driving the development of high-impact medical content for field teams and external stakeholders (20%).

Reporting to the Senior Director, Head of Global Medical Communications, this role requires strong ability to translate complex clinical, translational, and preclinical data into clear, accurate, and compliant scientific narratives that support medical strategy and product understanding.

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

## RESPONSIBILITIES

## PUBLICATION PLANNING AND EXECUTION (60%)

- Cross-Functional Leadership: Lead the Publications Planning Team to drive development of the global publication plan, incorporating strategic input from Clinical Development, Research, Biostats, Regulatory, Legal, and Corporate Communications.
- Tactical Delivery: Oversee the end-to-end development of manuscripts, abstracts, posters, oral presentations, and digital publication extenders for high-impact peer-reviewed journals and major scientific congresses.
- Review & Compliance: Facilitate author and internal reviews, including navigating the Medical-Legal-Regulatory (MLR) approval process, while ensuring strict compliance with GPP2022 and ICMJE guidelines.
- Vendor & Budget Oversight: Partner with and manage external scientific communication and medical writing agencies to ensure high-quality deliverables, timeline adherence, and budget optimization.

## SCIENTIFIC COMMUNICATION PLATFORM PULL THROUGH (20%)

- Scientific Messaging Alignment: Ensure all generated publications and medical deliverables strictly align with the established SCP, core lexicon, and broader Medical Affairs strategy set by leadership.
- Operational Integration: Partner with internal teams to pull the established scientific narratives through into ongoing Medical Affairs activities, maintaining message consistency across global and regional outputs.
- Literature Tracking: Monitor the external literature and competitive landscape to ensure internal reference libraries and execution timelines remain accurately aligned with the current asset landscape.

SCIENTIFIC CONTENT DEVELOPMENT (MSL & FIELD MEDICAL SUPPORT) (20%)

- Field Resource Creation: Assist with development of high-impact medical slide decks, FAQs, training materials, and interactive educational tools to enable effective field-based scientific exchange.
- Congress & Advisory Support: Support preparation of data-driven materials for medical advisory boards and key scientific congresses.
- Data Continuity: Partner with Clinical Development and Medical Strategy to ensure incorporation of new clinical data into field-facing materials.
- Scientific Compliance: Ensure all developed resources are scientifically accurate, fair-balanced, evidence-based, and fully compliant with internal and regulatory compliance frameworks.

## QUALIFICATIONS

## REQUIRED

- Education: Advanced degree (PhD, PharmD, MD, or MSc) with 6+ years of experience in Medical Affairs, Scientific Communications, or Publication Management.
- Experience: Proven track record of directly managing the tactical planning, drafting, and execution of scientific publications in the biotech or pharmaceutical industry.
- Compliance & Guidelines: Expert knowledge and practical application of Good Publication Practices (GPP2022) and ICMJE guidelines.
- Data Interpretation & Communication: Strong ability to interpret clinical trial data and simplify complex scientific concepts into clear, accurate medical messaging.
- Project & Vendor Management: Strong hands-on experience managing external medical writing and scientific communication agencies, ensuring strict timeline adherence and budget management.
- Organizational Excellence: Exceptional organizational and time-management skills, with a proven ability to prioritize a high volume of deliverables in a fast-paced, deadline-driven environment.
- Cross-Functional Collaboration: Proven ability to influence and manage stakeholder input across a highly matrixed cross-functional team (e.g., Clinical, Biostats, Regulatory, Legal).
- Attention to Detail: Meticulous editorial and review capabilities with strong compliance awareness and dedication to quality control.

## PREFERRED & ADDITIONAL QUALIFICATIONS

- Therapeutic Area Expertise: Oncology or immuno-oncology experience is highly preferred.
- Professional Certification: ISMPP Certified Medical Publication Professional (CMPP) credential is highly desirable.
- System Familiarity: Proficiency with modern publication management software (e.g., iEnvision/Datavision, PubsHub) and Medical-Legal-Regulatory (MLR) review platforms (e.g., Veeva PromoMats/MedComms).
- Scientific Writing: Strong scientific writing background, capable of providing rigorous directional feedback to agency partners.

## COMPANY OVERVIEW

Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com http://www.bicara.com.

Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.

Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

## About Bicara Therapeutics

## Company Overview
- **One-liner**: Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class bifunctional antibodies that combine tumor-targeting with tumor microenvironment modulation, with a lead asset in head and neck squamous cell carcinoma.
- **Entity Type**: Public (NASDAQ: BCAX)
- **Headquarters**: Boston, Massachusetts, USA
- **Founded**: 2020
- **Founders**: Not publicly listed

## Core Business
- **Industry**: Biotechnology – oncology drug development
- **Target Customers**: B2B (pharma partnerships, licensing) and ultimately cancer patients and healthcare providers
- **Mission**: "Dedicated to improving the lives of people living with cancer through the development of innovative targeted therapies… bringing hope and control back into their lives." [bicara.com](https://www.bicara.com/)

## Products & Services
- **[Ficerafusp alfa (BCA101)](https://www.bicara.com/)**: First-in-class, dual-action bifunctional antibody targeting EGFR and containing a TGF-β ligand trap. Currently in Phase 1/1b clinical development for HPV-negative head and neck squamous cell carcinoma and other solid tumors. Mechanism designed to deliver an immunomodulatory payload directly to the tumor microenvironment, reduce fibrosis/immunosuppression, and enable immune cell penetration. (Biologic, clinical-stage therapeutic)

## Market Standing
- **Valuation/Market Cap**: ~$1.3 billion (as of mid-2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Key Metric**: Total funding raised $825M (includes Series C $165M led by The Rise Fund and TPG, $362M from 2024 IPO, and a $150M post-IPO equity round in February 2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Notable Investors/Partners**: The Rise Fund, TPG, Biocon (seed round). Additional institutional investors from IPO and follow-on offerings.
- **Growth Signals**: IPO completed September 2024; headcount grew 78.1% year-over-year (95 employees, though LinkedIn notes a slight monthly decline of -0.9%); operates across 8 countries including the UK, Italy, Germany, India, and Spain; 11 active job postings as of mid-2026. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)

## Competitive Advantages
- **First-in-class bifunctional approach**: By combining an EGFR-targeting antibody with a TGF-β trap, BCA101 directly addresses a key solid-tumor resistance mechanism (TGF-β-driven immunosuppression and fibrosis) while localizing therapy to the tumor.
- **Potential for superior efficacy and safety**: Designed to deliver synergistic therapeutic impact at the tumor site, aiming for deep, durable responses with reduced systemic toxicity.
- **Experienced leadership**: Team with deep oncology drug development backgrounds and relationships with top cancer centers. [bicara.com/about](https://www.bicara.com/about/)

## Strategic Focus
- **Priority**: Advancing ficerafusp alfa through clinical development toward potential regulatory approvals, initially in HPV-negative head and neck squamous cell carcinoma.
- **Pipeline expansion**: Leveraging the bifunctional antibody platform (BCA101 and follow-on programs) to address multiple solid tumor types.
- **Commercial readiness**: Hiring senior roles in medical affairs, quality, regulatory, and commercial operations signals preparation for launch. [bicara.com/careers](https://www.bicara.com/careers/)

## Why Work Here
- **Culture & Mission**: A patient-first, mission-driven environment focused on developing meaningful new therapies for cancer. Company describes itself as "dynamic" with a shared passion for advancing science. [bicara.com](https://www.bicara.com/)
- **Diversity & Inclusion**: Explicitly states commitment to building diverse teams and encourages applicants from all backgrounds. [bicara.com/careers](https://www.bicara.com/careers/)
- **Growth Trajectory**: Fast-growing public company (78% headcount growth YoY) with a strong balance sheet, offering career progression opportunities.
- **Work Environment**: Headquarters in Boston with a global presence. Specific remote/hybrid policy not publicly detailed, but the company employs staff across 8 countries. Glassdoor rating of 4.0/5 on LinkedIn based on limited reviews. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Engagement**: Active hiring across multiple senior-level roles in medical affairs, regulatory, quality, IT, and clinical operations, indicating a ramp-up toward commercialization. [bicara.com/careers](https://www.bicara.com/careers/)

## Sources
1. [bicara.com](https://www.bicara.com/) – Company home page, product, mission
2. [bicara.com/about](https://www.bicara.com/about/) – Leadership team, technology description
3. [bicara.com/careers](https://www.bicara.com/careers/) – Open positions, culture, diversity statement
4. [linkedin.com/company/bicara-therapeutics](https://www.linkedin.com/company/bicara-therapeutics) – Headcount, financials, stock info, employee reviews, talent sources
5. [massbio.org/members/bicara-therapeutics](https://www.massbio.org/members/bicara-therapeutics/) – Membership description, pipeline summary

## Other roles at Bicara Therapeutics

- [Senior Manager, GxP Audit Program Lead](https://feeny.ai/job/senior-manager-gxp-audit-program-lead-bicara-therapeutics-boston-z2743dyfw8v5) — Boston, MA
- [Director, Biostatistics](https://feeny.ai/job/director-biostatistics-bicara-therapeutics-boston-8acrty1k88h7) — Boston, MA
- [Director, Marketing Operations](https://feeny.ai/job/director-marketing-operations-bicara-therapeutics-boston-308n8g5t9f73) — Boston, MA
- [Senior Medical Science Liaison - West (CA, WA)](https://feeny.ai/job/senior-medical-science-liaison-west-ca-wa-bicara-therapeutics-united-states-tv5xs4prg9y2) — United States
- [Associate Director, Financial Planning & Analysis (Development Finance Business Partner)](https://feeny.ai/job/associate-director-financial-planning-analysis-development-finance-business-nt8nz0xbxns1) — Boston, MA
- [Senior Manager, Accounting and SEC Reporting](https://feeny.ai/job/senior-manager-accounting-and-sec-reporting-bicara-therapeutics-boston-hngf1v66tht9) — Boston, MA
- [Sr. Quality Specialist, GxP Document Control](https://feeny.ai/job/sr-quality-specialist-gxp-document-control-bicara-therapeutics-boston-pmtejzsn39sj) — Boston, MA
- [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-bicara-therapeutics-boston-07s96d5xygx4) — Boston, MA
- [Associate Director, Project Management (Clinical Operations)](https://feeny.ai/job/associate-director-project-management-clinical-operations-bicara-therapeutics-jc50anna3jrm) — United States
- [Senior Director, Regulatory Affairs](https://feeny.ai/job/senior-director-regulatory-affairs-bicara-therapeutics-boston-t7b77r839mdy) — Boston, MA